- Home
- EVEX vs CVAC Comparison
EVEX vs CVAC Comparison
Compare EVEX & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVEX | CVAC |
|---|---|---|
| Founded | 2020 | 2000 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | EVEX | CVAC |
|---|---|---|
| Price | $4.81 | $4.19 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $6.88 | $6.83 |
| AVG Volume (30 Days) | 1.8M | ★ 1.9M |
| Earning Date | 11-04-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.02 |
| EPS | N/A | ★ 0.94 |
| Revenue | N/A | ★ $83,000,117.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23.40 |
| P/E Ratio | ★ N/A | $4.44 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.83 | $2.48 |
| 52 Week High | $7.70 | $5.72 |
Technical Indicators
Market Signals| Indicator | EVEX | CVAC |
|---|---|---|
| Relative Strength Index (RSI) | 59.48 | 22.96 |
| Support Level | $4.58 | $4.07 |
| Resistance Level | $5.16 | $5.20 |
| Average True Range (ATR) | 0.31 | 0.15 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 64.52 | 7.66 |
Price Performance
Historical ComparisonAbout EVEX Eve Holding Inc.
Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.